| Members |
targetComponentId |
| Drug cream, 0,5% |
Cream |
| Drug cream, 1% |
Cream |
| Drug cream, 2,5% |
Cream |
| Drug gel, 0,05% |
Gel |
| Drug gel, 0,1% |
Gel |
| Drug gel, 0,25% |
Gel |
| Drug groups primarily affecting the autonomic nervous system |
Product containing autonomic agent (product) |
| Drug ointment, 0,025% |
Ointment |
| Drug ointment, 0,05% |
Ointment |
| Drug ointment, 0,1% |
Ointment |
| Drug ointment, 0,2% |
Ointment |
| Drug ointment, 0,25% |
Ointment |
| Drug ointment, 1% |
Ointment |
| Drug ointment, 2,5% |
Ointment |
| läkemedelsspecifikt allergenextrakt |
Pharmaceutical / biologic product (product) |
| krampanfall vid drogabstinens |
Seizure co-occurrent and due to drug withdrawal (disorder) |
| Drug, medicament or biological substance |
Drug or medicament (substance) |
| substansutlöst impotens |
Erectile dysfunction caused by drug |
| läkemedel för behandling av hyperurikemi |
Uricosuric agent |
| läkemedel för behandling av ämnesomsättningsstörningar |
Medicinal product categorised by therapeutic role |
| Drusen |
Hyaline body |
| duktal ektasi |
Dilatation |
| duktalt carcinoma in situ, kategori |
Non-infiltrating intraductal carcinoma |
| Dukes sjukdom |
Rubeola scarlatinosa |
| CVS-riskbedömningsskala enligt Dundee-universitet |
Dundee Coronary Risk Disk (assessment scale) |
| dubblerat begrepp |
Duplicate component (foundation metadata concept) |
| kopia av utlåtande |
Duplicate report (record artifact) |
| Dupuytrens kontraktur opererad genom delning av palmaraponeuros |
Dupuytren contracture corrected by division of palmar aponeurosis |
| Dyclonine hydrochloride 1% topical solution (product) |
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| dynamit |
Dynamite stick (physical object) |
| dyfyllin 100 mg + guajfenesin 100 mg, elixir |
Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug) |
| dyfyllin 160 mg/15 ml, elixir |
Diprophylline 10.7 mg/mL oral solution |
| Dyskinesia of esophagus |
Diffuse spasm of esophagus |
| dyssegmental dysplasi med glaukom |
Rolland-Debuqois syndrome |
| Dyssocial behavior of child or adolescent |
Dyssocial behavior of child or adolescent (finding) |
| Dysthyroid ophthalmopathy |
Exophthalmos due to thyroid eye disease (disorder) |
| rapport per e-post |
E-mail report (record artifact) |
| ECG equivocal |
ECG equivocal |
| ECG: left ventricular strain |
ECG: left ventricular strain |
| Ear sign or symptom |
fynd som rör öra och hörsel |
| kronisk oligoartrit med tidig debut |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
| Ebola virus |
Genus Ebolavirus (organism) |
| Ebola virus Ivory Coast subtype |
Ivory Coast ebolavirus (organism) |
| Ebola virus Reston biotype |
Reston ebolavirus (organism) |
| Ebola virus Sudan biotype |
Sudan ebolavirus (organism) |
| Ebola virus Zaire biotype |
Zaire virus (organism) |
| Ebola virus disease |
Ebola virus disease |
| Echinococcus granulosus infection of other site |
Echinococcus granulosus infection |
| Echinococcus multilocularis infection of other site |
Echinococcus multilocularis infection |
| Echinocyte |
Burr cell |
| fosfolinjodid 0,03 %, ögondroppar |
Ecothiopate iodide 300 microgram/mL eye solution |
| fosfolinjodid 0,06 %, ögondroppar |
Product containing precisely ecothiopate iodide 600 microgram/1 milliliter conventional release eye solution (clinical drug) |
| fosfolinjodid 0,125 %, lösning |
Ecothiopate (as ecothiopate iodide) 1.25 mg/mL eye solution |
| fosfolinjodid 0,25 %, ögondroppar |
Ecothiopate iodide 2.5 mg/mL eye solution |
| ekonazolnitrat vagitorium 150 mg + kräm 1 % |
Econazole only product |
| fosfolinjodid 0,125 %, ögondroppar |
Ecothiopate iodide 1.25 mg/mL eye solution |
| Ectopic hormone secretion, NEC |
Ectopic production of endocrine substance |
| eksem på ben |
Eczema of lower limb |
| dinatriumedetat 150 mg/ml, injektionsvätska, lösning, ampull |
Edetate disodium 150 mg/mL solution for injection |
| Educational status |
Educational achievement |
| Educational therapy |
Educational therapy |
| Edwardsiella anguillimortifera |
Edwardsiella tarda |
| ål, livsmedel |
Eel (substance) |
| eflornitinhydroklorid 13,9 %, kräm |
Eflornithine (as eflornithine hydrochloride) 139 mg/mL cutaneous cream |
| Eflornithine hydrochloride 139mg/g cream |
Eflornithine (as eflornithine hydrochloride) 139 mg/mL cutaneous cream |
| EgAn1824-61 virus |
EgAN 1825-61 virus (organism) |
| Egyptian goose breed (organism) |
Alopochen aegyptiacus |
| Ehlers-Danlos syndrom, vaskulärliknande typ |
Ehlers-Danlos syndrome classic type (disorder) |
| Ehlers-Danlos syndrom med periventrikulär heterotopi |
Periventricular nodular heterotopia |
| Ehlers-Danlos syndrom, dominant typ 4 |
Ehlers-Danlos syndrome, type 4 |
| Ehlers-Danlos syndrom, recessiv typ 4 |
Ehlers-Danlos syndrome, type 4 |
| Ehrlichia equi |
Anaplasma phagocytophilum (organism) |
| Ehrlichia phagocytophila |
Anaplasma phagocytophilum (organism) |
| Ehrlichia platys |
Anaplasma platys (organism) |
| Ehrlichia risticii |
Neorickettsia risticii (organism) |
| Ehrlichia sennetsu |
Neorickettsia sennetsu (organism) |
| Ejaculatio tarda |
Late ejaculation |
| Ejaculation |
Ejaculation |
| Elapid snake |
Family Elapidae |
| Electrical fitter (general) |
Electrical fitter |
| Electrolyte and fluid disorder, NEC |
Disorder of fluid AND/OR electrolyte |
| medel innehållande elektrolytanjon |
Electrolyte anion (substance) |
| Electromyogram |
Electromyography |
| Electron |
Electron |
| Elevated |
High |
| Embden-Meyerhof pathway |
Embden-Meyerhof pathway |
| Emblema guttata |
Stagonopleura guttata (organism) |
| Embolectomy - action |
Removal - action |
| Embolism of mesenteric artery |
Embolic mesenteric infarction |
| Embolism of renal vein |
Embolism of renal vein |
| embryonal cysta hos cervikala, vaginala och externa kvinnliga könsorgan |
Embryonic cyst of female genital structure |
| Embryonic nervous structure |
Embryonic nervous system structure |
| emeproniumbromidallergi |
Allergy to emepronium (finding) |
| akut inskrivning på grund av astma sedan förra besöket |
Emergency asthma admission since last encounter (situation) |
| Emetic drugs |
Emetic agent |
| emotionell miljö |
Emotional environment finding (finding) |
| enalaprilallergi |
Non-allergic hypersensitivity to enalapril (finding) |
| Enalapril maleate + hydrochlorothiazide |
Product containing enalapril and hydrochlorothiazide (medicinal product) |
| Enalapril maleate + hydrochlorothiazide tablet |
Product containing enalapril and hydrochlorothiazide (medicinal product) |
| enalaprilmaleat 5 mg + felodipin 2,5 mg, tablett med modifierad frisätttning |
Enalapril and felodipine only product in oral dose form |
| enalaprilmaleat 5 mg + felodipin 2,5 mg, depåtablett |
Enalapril and felodipine only product in oral dose form |
FHIR